Search Within

Solid Tumor Oncology Division

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (1072)
  2. Meeting Abstract (1015)
  3. Review (54)
  4. Book Section (40)
  5. Editorial (36)
  6. Research Letter (20)
  7. Guidelines (11)
  8. Conference Paper (7)
  9. Correspondence (5)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2265)
  2. Hematologic Malignancies, Division of (2265)
  3. GSK Faculty (946)
  4. Center for Hematologic Malignancies (701)
  5. Genitourinary Oncology Service (651)
  6. Epidemiology and Biostatistics (632)

More Groups

People
  1. Roisin O'Cearbhaill (269)
  2. Susan Slovin (253)
  3. Sandra D'Angelo (251)
  4. Alexander Shoushtari (244)
  5. Geoffrey Ku (229)
  6. Howard Scher (206)

More People

Years
  1. 2025 (59)
  2. 2024 (171)
  3. 2023 (205)
  4. 2022 (224)
  5. 2021 (183)
  6. 2020 (212)

More Years

Publications
  1. Journal of Clinical Oncology (542)
  2. Blood (113)
  3. Clinical Cancer Research (98)
  4. Annals of Oncology (97)
  5. Gynecologic Oncology (94)
  6. Journal for ImmunoTherapy of Cancer (75)

More Publications

Publishers
  1. American Society of Clinical Oncology (569)
  2. Elsevier Inc. (280)
  3. American Association for Cancer Research (235)
  4. Oxford University Press (126)
  5. Nature Publishing Group (121)
  6. American Society of Hematology (118)

More Publishers

Results (2265)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral blood progenitor cell (PBP) mobilization using Taxol (T) in combination with cyclophosphamide (C) and GCSF; Quantitation and correlation of CD34+ cell count, colony-forming-unit granulocyte-macrophage (CFU-GM), and mononuclear cell (MNC) count
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Reich, L.; Norton, L.; Spriggs, D.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • Long-term hematopoiesis is not affected by rapid cycling of sequential high dose chemotherapy (HDC) prior to full hematologic recovery
    Meeting Abstract

    Tiersten, A.; Raptis, G.; Crown, J.; Vahdat, L.; Hamilton, N.; Reich, L.; Damaskos, P.; Norton, L.
    Blood (1994)

    Fulltext@MSK | Save
  • Comparative efficacy of bone marrow engraftment following high-dose (HD) carboplatin (CBDCA) plus cyclophosphamide versus high-dose CBDCA/Taxol (TXL), when rescued with TXL cyclophosphamide (CPA) and GCSF mobilized peripheral blood progenitor cells (PBP)
    Meeting Abstract

    Fennelly, D.; Shapiro, F.; Schneider, J.; Spriggs, D.; Bengala, C.; McKenzie, M.; Reich, L.; Norton, L.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • High-intensity chemotherapy with peripheral blood progenitor cell support
    Conference Paper

    Fennelly, D.; Vahdat, L.; Schneider, J.; Reich, L.; Hamilton, N.; Hakes, T.; Raptis, G.; Wasserheit, C.; Kritz, A.; Gulati, S.; more...
    Elsevier Inc. (1994)

    Fulltext@MSK | Save
  • Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: A phase I trial
    Journal Article

    Fennelly, D.; Wasserheit, C.; Schneider, J.; Hakes, T.; Reich, L.; Curtin, J.; Yao, T. J.; Markman, M.; Norton, L.; Crown, J.
    Cancer Research (1994)

    Fulltext@MSK | Save
  • Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients
    Journal Article

    Schneider, J. G.; Crown, J. P.; Wasserheit, C.; Kritz, A.; Wong, G.; Reich, L.; Norton, L.; Moore, M. A. S.
    Bone Marrow Transplantation (1994)

    Fulltext@MSK | Save
  • Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma
    Journal Article

    Offit, K.; Lo Coco, F.; Louie, D. C.; Parsa, N. Z.; Leung, D.; Portlock, C.; Ye, B. H.; Lista, F.; Filippa, D. A.; Rosenbaum, A.; more...
    New England Journal of Medicine (1994)

    Fulltext@MSK | Save
  • Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PMN/RAR-α isoform, and CD13 expression in patients treated with all-trans retinoic acid
    Journal Article

    Vahdat, L.; Maslak, P.; Miller, W. H. Jr; Eardley, A.; Heller, G.; Scheinberg, D. A.; Warrell, R. P. Jr
    Blood (1994)

    Fulltext@MSK | Save
  • Optimization of conditions for ex vivo expansion of CD34(+) cells from patients with stage IV breast cancer
    Journal Article

    Shapiro, F.; Yao, T. J.; Raptis, G.; Reich, L.; Norton, L.; Moore, M. A. S.
    Blood (1994)

    Fulltext@MSK | Save
  • Chemotherapeutic liver infusion
    Book Section

    Kemeny, N. E.; Younes, A.
    In Wanebo, H. J. (Eds.) Colorectal Cancer (1993)

    Fulltext@MSK | Save